P1151: METABOLIC TUMOR VOLUME IMPROVES OUTCOME PREDICTION IN UNTREATED MANTLE CELL LYMPHOMA

por Vergote, V. K., Verhoef, G., Janssens, A., Woei-a-jin, F. S., Laenen, A., Tousseyn, T., Dierickx, D., Deroose, C. M.
Publicado 2022

Whole-body diffusion-weighted imaging for staging lymphoma: are apparent diffusion coefficient derived histogram parameters useful for lesion characterisation?

por De Paepe, K, De Keyzer, F, Wolter, P, Bechter, O, Janssens, A, Dierickx, D, Oyen, R, Verhoef, G, Vandecaveye, V
Publicado 2014

Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma

por Dreyling, M., Morschhauser, F., Bouabdallah, K., Bron, D., Cunningham, D., Assouline, S. E., Verhoef, G., Linton, K., Thieblemont, C., Vitolo, U., Hiemeyer, F., Giurescu, M., Garcia-Vargas, J., Gorbatchevsky, I., Liu, L., Koechert, K., Peña, C., Neves, M., Childs, B. H., Zinzani, P. L.
Publicado 2017

High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study

por Deenik, W., van der Holt, B., Verhoef, G. E. G., Schattenberg, A. V. M. B., Verdonck, L. F., Daenen, S. M. G. J., Zachée, P., Westveer, P. H. M., Smit, W. M., Wittebol, S., Schouten, H. C., Löwenberg, B., Ossenkoppele, G. J., Cornelissen, J. J.
Publicado 2006